| Type 2 diabetes - controlling hyperglycaemia with early insulin use. | |
| | |
MedLine Citation:
|
PMID: 20877750 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Many patients with type 2 diabetes need to progress to insulin use when oral glucose lowering therapies fail to maintain adequate glycaemic control. OBJECTIVE: To suggest when and how to initiate insulin therapy for patients with type 2 diabetes in the primary care setting. DISCUSSION: In general, initiation of insulin should be considered in individuals on maximal tolerated doses of metformin and sulfonylureas with HbA1c levels >7.0% over a 3-6 month period. Current Australian guidelines recommend initiating insulin therapy as once daily basal therapy or as premixed insulins. |
| | |
Authors:
|
Richard MacIsaac; Ada Cheung; George Jerums |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Australian family physician Volume: 39 ISSN: 0300-8495 ISO Abbreviation: Aust Fam Physician Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-09-29 Completed Date: 2010-12-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0326701 Medline TA: Aust Fam Physician Country: Australia |
Other Details:
|
Languages: eng Pagination: 565-9 Citation Subset: IM |
Affiliation:
|
University of Melbourne, Victoria. r.macisaac@unimelb.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Australia Blood Glucose / drug effects Diabetes Mellitus, Type 2 / drug therapy* Humans Hyperglycemia / drug therapy* Hypoglycemic Agents / administration & dosage*, therapeutic use Insulin / administration & dosage*, therapeutic use Practice Guidelines as Topic Thiazolidinediones / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Hypoglycemic Agents; 0/Thiazolidinediones; 11061-68-0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Managing a difficult periorbital skin cancer.
Next Document: Yellow fever - prevention in travellers.